Inhalation therapy for bronchial asthma in the conditions of paediatric section
https://doi.org/10.21518/2079-701X-2020-10-108-114
Abstract
The prevalence of bronchial asthma among children in different regions of Russia ranges from 10.9–9.6‰ to 50–55‰. The frequency of bronchial asthma among lyceum students is 33.1‰, while in the most overcrowded school it is 45.8‰. Bronchial asthma occurs more frequently in the mild, less frequently in the medium form. Therefore, the main burden on the management of such patients falls on the ambulatory segment. Diagnosed on the basis of respiratory symptoms such as wheezing, difficulty breathing, strain and bloating of the chest, coughing. Asthmatic attack with bronchial asthma of any degree of severity can be as severe or even asthmatic status, which, along with the prevalence of bronchial asthma, determines the primary importance of ambulatory control of the disease. It is fundamental to suppress local bronchial inflammation and remove bronchospasm. Adequacy and systematic treatment is essential for the outcome of bronchial asthma in children. Timely anti-inflammatory treatment can lead to remission. Inhalation techniques of anti-inflammatory drugs and bronchodilators are the most optimal. The possibility of application of beclometasone (inhalation glucocorticosteroid), a combination of fluticasone and salmeterol, ipratropium bromide of Russian manufacture, which efficiency is proved in practical work and economically justified, is considered. IGCS, acting locally, have a pronounced anti-inflammatory activity, suppressing both acute and chronic inflammation. Clinical examples of children with atopic dermatitis and the revealed diagnosis of bronchial asthma, with an optimum choice of treatment are given. It is proved that application of modern inhalation drugs in complex treatment leads to bronchial asthma remission.
About the Author
W. V. Delyagin
National Medical Research Center for Children’s Hematology, Oncology and Immunology named after Dmitry Rogachev
Russian Federation
Russian Federation
Wassili V. Delyagin, Dr. of Sci. (Med), Professor of the Department of Pediatrics and Healthcare Organization, Head of Clinical Physiology Department
1, Samora Mashel St., Moscow, 117997
References
1. Bateman E.D., Hurd S.S., Barnes P.J., Bousquet J., Drazen J.M., FitzGerald J.M. et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 2008;31:143–178. doi: 10.1183/13993003.51387-2007.
2. Budchanov Y.I., Delyagin V.M. Genetics of bronchial asthma. Prakticheskaya meditsina = Practical medicine. 2010;6(45):19–21. (In Russ.) Available at: https://elibrary.ru/item.asp?id=15263796.
3. Delyagin V.M., Rumyantsev A.G. Bronchial asthma in children. Modern pathogenesis concept, step-by-step therapy and β2-agonists. Practitioner’s Guide. Мoscow: MAKS Press; 2004. 128 p. (In Russ.)
4. Classen M., Illing S. (eds.) Klinikleitfaden Pädiatrie. 9 th ed. München: Urban&Fischer; 2014. 864 s.
5. Elizalde-Beiras J., Guillen-Grima F., Anguinaga-Ontoso J. Prevalence of Asthma in Children and Adolescents in Rural Area. Archives of Bronchology. 2017;53(8):460–461. doi: 10.1016/j.arbres.2016.12.012
6. Castro-Rodriguez J.A. The Asthma Predictive Index: early diagnosis of asthma. Curr Opin Allergy Clin Immunol. 2011;11(3):157–161. doi: 10.1097/ACI.0b013e3283464c4a.
7. Asthma. In: Marcdante K., Kliegman R. Nelson essentials of pediatrics. 8 th ed. Elsevier; 2019.
8. Becker A. Guidelines for Treatment of Asthma: a Global Concern. In: Leung D., Szefler S., Bonilla F., Akdis C., Smpson H.A. (eds.) Pediatric Allergy: Principles and Practice. 3 rd ed. Elsevier; 2016, рр. 262–266. doi: 10.1016/B978-0-32329875-9.00029-X.
9. Volkov I.K., Geppe N.A., Kondyurina E.G., Malakhov A.B., Mizernitskiy Yu.L., Revyakina V.A., Sidorenko I.V. National program «Bronchial asthma in children. Treatment and prevention strategy». 3 rd ed., Мoscow: Atmosphere; 2008. 108 p. (In Russ.) Available at: http://atm-press.ru/wp-content/uploads/2018/03/Natprog-3-ba-deti.pdf.
10. Lukina O.F., Petrenets T.N., Delyagin V.M. Bronchophonography parameters in healthy children under 7 years of age. Klinicheskaya i neotlozhnaya pediatriya: novosti, mneniya, obuchenie = Clinical and emergency pediatrics: news, opinions, training. 2015;(1):59–61. (In Russ.)
11. Delyagin V.M., Aksyonova N.S., Klyuchnikova I.V. Child, asthma, doctor and school. Prakticheskaya meditsina = Practical medicine. 2017;(10):26–32. (In Russ.) Available at: https://elibrary.ru/item.asp?id=30676122.
12. Collins S., Widberg J., Davis A., Massie J. Management of asthma in Children with long QT Syndrome. Ped Resp Rev. 2012;13(2):100–105. doi: 10.1016/j.prrv.2011.02.003.
13. Haarman M., Hunsel van F., Vries de T. Advers drug reaction of montelucast in children and adults. Pharma Res Per. 2017;5(5):e00341. doi: 10.1002/prp2.341.
14. Hernandez-Trujillp V., Riley E., Rudnik Ch. Allergy. In: Rakel R.E., Rakel D.P. (eds.) Textbook of Family Medicine. 9 th ed. 2016, рр. 351–364. Available at: http://familymed.sbmu.ac.ir/uploads/textbook_family_medicine_rakel.pdf.
15. Rieger C., von der Hardt H., Sennhauser F.H., Wahn U., Zach M.S. (Hrsg.) Pädiatrische Pneumologie. Berlin, Springer; 2004. 1157 p.
Review
For citations:
Delyagin WV. Inhalation therapy for bronchial asthma in the conditions of paediatric section. Meditsinskiy sovet = Medical Council. 2020;(10):108-114. (In Russ.) https://doi.org/10.21518/2079-701X-2020-10-108-114
Views:
672
Email this article 